Description Miropriston (Mifepristone) is a synthetic antiprogestational steroid agent. It blocks the effects of progesterone at the receptor level, increasing myometrial contractility. It is indicated for the medical termination of early intrauterine pregnancy and for labor induction. Administration Medical Supervision Required: Must be administered exclusively in specialized healthcare facilities under strict medical control. Usage: The specific treatment regimen is determined by a qualified healthcare professional. The medication is taken orally in the presence of a physician. Follow-up: Following administration, the patient must remain under medical observation for a designated period to ensure safety and monitor the clinical progress. Contraindications Suspected ectopic pregnancy. Adrenal insufficiency or long-term corticosteroid therapy. Hemostasis disorders (including concurrent anticoagulant therapy) or severe anemia. Acute or chronic renal or hepatic failure. Hypersensitivity to mifepristone or any components of the drug.